16 March 2021 |

Bio-Gate CEO Marc Lloret-Grau reports on the successful cooperation with clinics in the field of innovative medical products in newspaper F.A.Z.

March 2021 - When implants and prostheses are used surgically, there is always a high risk of infection for the patient. Bio-Gate has developed the antiviral and antimicrobial implant coating “HyProtect” especially for this area. It is already being used with great success at the Regensburg University Hospital. Bio-Gate and the clinic have been cooperating for years – to the benefit of patients and science. Direct feedback from patients and surgeons is valuable capital for companies like Bio-Gate, which can continue to work on future innovations on this basis.


More information on the collaboration between medicine and research-based companies like

Bio-Gate can be found here:




linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram